Eight German elderly workers mistakenly overdosed on Pfizer Covid vaccine

A pharmacist administers a dose of the Pfizer-BioNTech Covid-19 vaccine

Eight elderly workers at a German care home were mistakenly injected with five times the recommended dose of the Pfizer/Biontech vaccine, local authorities said Monday.

The incident happened on Sunday in the northeastern city of Stralsund in the Vorpommern-Ruegen district. District chief Stefan Kerth said in a statement that he regretted the mishap.

"I deeply regret the incident. This single event is the result of an individual mistake. I hope that all those affected will not develop serious side-effects," he said.

Those injected with the drug were aged between 66 and 82. They were sent home as soon as the mistake came to light. Four developed flu-like symptoms and were hospitalized for observation.

The district authority pointed out that the vaccine's German developer, Biontech, had used higher doses during the first phase of trials and observed no lasting side-effects in the volunteers.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel